Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Psoriatic arthritis

Two sides of management recommendations for psoriatic arthritis

Nature Reviews Rheumatology (2024)Cite this article

Subjects

Guidelines for the management of psoriatic arthritis (PsA) need to undergo revision to take on board new evidence, particularly in relation to therapeutics. In March 2024, EULAR published updated recommendations for the pharmacological treatment of PsA, and an expert group published consensus statements intended to complement existing guidelines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lubrano, E., Scriffignano, S. & Perrotta, F. M. Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? J. Rheumatol. 46, 1428–1430 (2019).

    Article  PubMed  Google Scholar 

  2. Gossec, L. et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2024-225531 (2024).

  3. Gossec, L. et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann. Rheum. Dis. 79, 700–712 (2020).

    Article  PubMed  Google Scholar 

  4. Coates, L. C. et al. GRAPPA Treatment Recommendations domain subcommittees. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat. Rev. Rheumatol. 18, 465–479 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Coates, L. & Gossec, L. The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: similarities and differences. Joint Bone Spine 90, 105469 (2023).

    Article  PubMed  Google Scholar 

  6. Coates, L. C. et al. Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel. Rheumatology https://doi.org/10.1093/rheumatology/keae172 (2024).

  7. Ytterberg, S. R. et al. ORAL Surveillance Investigators. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N. Engl. J. Med. 386, 316–326 (2022).

    Article  CAS  PubMed  Google Scholar 

  8. Queiro, R. et al. Severe disease in patients with recent-onset psoriatic arthritis. Prediction model based on machine learning. Front. Med. 28, 891863 (2022).

    Article  Google Scholar 

  9. Lubrano, E., Scriffignano, S., Fatica, M. & Perrotta, F. M. Potential differences in clinical features, disease activity, function and impact of disease between oligo and polyarticular psoriatic arthritis. J. Psoriasis Psoriatic Arthritis 6, 38–42 (2021).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”, Università degli Studi del Molise, Campobasso, Italy

    Ennio Lubrano & Fabio Massimo Perrotta

Authors
  1. Ennio Lubrano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabio Massimo Perrotta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ennio Lubrano.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lubrano, E., Perrotta, F.M. Two sides of management recommendations for psoriatic arthritis. Nat Rev Rheumatol (2024). https://doi.org/10.1038/s41584-024-01127-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41584-024-01127-3

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing